Opinion|Videos|January 9, 2024
Identifying the Right CDMO to Support Biopharma Manufacturing
Author(s)Ascendia Pharma
Robert Bloder, Chief Business Officer, Ascendia Pharmaceuticals discusses:
- What to look for when identifying a CDMO for a drug development project
- Ascendia Pharmaceuticals and its expansion of manufacturing services
- Ascendia Pharmaceuticals as a "Partner of Choice"
Related Content
Trending on Pharmaceutical Technology
1
Putting Sustainability to Work in Pharma
2
Managing Global Trial Supply Risk: Expert Insights
3
Why Oral Solid Dosage Validation Is a Business Continuity Function, Not Just a Compliance Requirement
4
Technology Transfer: Success Drivers and Obstacles Explained
5